The structural gene for perfringolysin 0 (pfoA), a thiol-activated hemolysin of Clostridium perfringens, was cloned into Escherichia coli JM109 on a 4.6-kilobase (kb) EcoRI-NdeI fragment which contained the 1.7-kb pfoA gene and an upstream 2.9-kb region. An E. coli strain transformed by this plasmid produced 20-fold more perfringolysin 0 than a strain containing only the 1.7-kb pfoA gene. The stimulatory effect of the upstream region on in vivo expression of the pfoA gene was further analyzed by using a set of deletion mutants. Stimulation was still observed with a 3.9-kb fragment, but stimulation was not observed with fragments that were 3.6 kb or less long, indicating that the upstream region between 3.9 and 1.7 kb was Clostridium perfringens produces a number of toxins (12 toxins are known) which function in pathogenesis in animals and humans (9, 17). These toxin molecules have been well characterized by both biochemical and physiological studies. Genetic studies have been carried out recently, and some of the toxin genes have been cloned and sequenced (12, 22, 25, (30) (31) (32) . However, little is known about the mechanisms that regulate synthesis of the toxins. Production of the toxins seems to be regulated by complex factors, such as nutritional sources, salts, oxidoreduction potential, and other environmental conditions. Complex, varied sets of conditions may affect serious histolytic infections caused by C. perfringens, which is a dominant organism in the normal flora of human intestines. Molecular genetic studies on the mechanisms that regulate toxin production are a prerequisite for understanding the virulence of this organism.
Clostridium perfringens produces a number of toxins (12 toxins are known) which function in pathogenesis in animals and humans (9, 17) . These toxin molecules have been well characterized by both biochemical and physiological studies. Genetic studies have been carried out recently, and some of the toxin genes have been cloned and sequenced (12, 22, 25, (30) (31) (32) . However, little is known about the mechanisms that regulate synthesis of the toxins. Production of the toxins seems to be regulated by complex factors, such as nutritional sources, salts, oxidoreduction potential, and other environmental conditions. Complex, varied sets of conditions may affect serious histolytic infections caused by C. perfringens, which is a dominant organism in the normal flora of human intestines. Molecular genetic studies on the mechanisms that regulate toxin production are a prerequisite for understanding the virulence of this organism.
Imagawa et al. (10) isolated various types of C. perfringens mutants which differed in their production of four toxins, theta-toxin (perfringolysin 0), kappa-toxin (collagenase), lambda-toxin (protease), and hemagglutinin. One mutant lacked all four toxins, whereas the others could not produce one of the toxins but produced the rest of the toxins at wild-type levels. Imagawa et al. speculated that the mutant that lacked all four toxins had a mutation in a regulatory element shared by all four toxin genes and that the other mutants had mutations in single toxin genes; their speculation was supported by the results of a type of complementation experiment.
It has been suggested that positive regulation of the gene for listeriolysin 0, a thiol-activated hemolysin produced by Listeria monocytogenes, occurs, and a possible regulatory gene has been reported (19) .
In this paper, we describe the molecular cloning and sequencing of a 4.6-kilobase (kb) DNA fragment containing the C. perfringens pfoA gene and its regulatory gene, pfoR, and also describe effects of the pfoR gene on expression of the pfoA gene. * Corresponding author.
MATERIALS AND METHODS
Strains, phages, plasmids, and culture media. A gene library of C. perfringens type A strain NCTC 8237 in XgtlO (22) was used for cloning. Escherichia coli C600hflA (37) was used as a host for screening the library. E. coli HB101 (2) was used as a host for low-copy-number plasmid pTTS405 (27) , and E. coli JM109 (36) was used for plasmids pUC19 (36) and pACYC177 (4). E. coli strains were grown in L broth at 37°C. For strains harboring pTTS405 derivatives and strains harboring pUC19 derivatives, ampicillin was added to the media at final concentrations of 25 BamHI and PstI and deleted by using the kilo-sequence deletion kit (exonuclease III and mung bean nuclease).
Nucleotide sequencing. Nucleotide sequences were determined for a collection of deletion plasmids which contained successive deletions of 200 to 300 base pairs (bp). Each plasmid was prepared from a 10-ml culture by using a modified alkali rapid method and was treated with the Geneclean kit. Sequences were determined by using the dideoxy chain termination method (26) and 7-deazadeoxyguanosine triphosphate instead of dGTP. Most sequences were determined with the sequenase kit, while the Klenow kit was used to determine the nucleotide sequence near the primer annealing site.
Assays. E. coli JM109 cultures harboring pUC19 derivatives were grown in 100-ml portions of L broth containing 50 ,ug of ampicillin per ml to an optical density of 0.8 and then centrifuged at 8,000 x g for 10 min. The cell pellets were suspended in 40-ml portions of 0.032 M phosphate buffer (pH 6.8) containing 0.112 M NaCl. The cells were disrupted by ultrasonic treatment as described previously (21) . Hemolytic activity was assayed by using the method of Yamakawa and Sato (35) , except that erythrocytes were washed and suspended in 0.032 M phosphate buffer (pH 6.8) containing 0.112 M NaCl. The titer of hemolytic activity that gave 50% hemolysis was estimated from the calibration curve of A550 obtained from five different dilutions of each sample. Hemolytic activity was expressed as the reciprocal of the dilution which showed 50% hemolysis. ,-Lactamase activity was assayed by using the method of Lupski et al. (14) and was used to correct hemolytic activity for plasmid copy number. Protein concentrations were determined by the method of Lowry et al. (13) .
Other procedures. A lecithinase assay in which we used agar plates was performed as described previously (22) . A computer analysis was performed with DNASIS (Hitachi SK, Yokohama, Japan) and GENETYX (SDC Software, Tokyo, Japan) programs. Perfringolysin 0 was purified from a culture of strain NCTC 8237 as described elsewhere (35) .
Nucleotide sequence accession number. The GenBank accession number for the 4,600-bp nucleotide sequence discussed below (see Fig. 2 ) is M34727.
RESULTS
Cloning of the pfoA gene. A total of 63 Hly+ clones on blood agar were isolated from 8,275 plaques from the XgtlO library. All of these clones showed phospholipase C activity on egg yolk agar but no perfringolysin 0 hemolytic activity, indicating that all of the Hly+ clones expressed the plc gene. Addition of 20 mM EDTA to the blood agar inhibited phospholipase C activity, but did not affect hemolysis by perfringolysin 0 purified from a culture of C. perfringens. A total of 1,660 plaques from the XgtlO library, were screened for the Hly+ phenotype on blood agar containing 20 mM EDTA. One positive Hly+ clone was isolated and designated Xpfol. A lysate of Xpfol showed no phospholipase C activity on egg yolk agar; its hemolytic activity was completely inhibited by cholesterol, as expected. This result clearly indicated that Apfol contained the pfoA gene. A 6.9-kb EcoRI fragment from Xpfol was ligated into low-copynumber plasmid pTTS405 and transformed into E. coli HB101 (designated pTS101). Then pTS101 was partially digested with NdeI, and the 5' terminus was filled in with the Klenow fragment, ligated into the SmaI site of pUC19, and transformed into E. coli JM109. A plasmid containing a 4.6-kb fragment showed hemolytic activity and was designated pTS301. The restriction map of the 4.6-kb fragment is shown in Fig. 1 . pTS301 was then deleted with exonuclease III, and a series of deletion mutants were collected. An assay for perfringolysin 0 hemolytic activity on blood agar showed that a 1.7-kb fragment was the smallest fragment which expressed the pfoA gene ( Fig. 1) .
It should be noted that the pTS301 clone showed much stronger hemolytic activity than other clones. Strong hemolysis was also observed with pTS302 containing a 3.9-kb fragment but not with pTS304 ( Fig. 1 ). This might have been due to activation of pfoA gene expression by its upstream region. Therefore, the entire pTS301 insertion was sequenced.
Nucleotide sequence and deduced amino acid sequence. The 4,600-bp nucleotide sequence is shown in Fig. 2 . The dAplus-dT content of this fragment was 73.5 mol%, which is similar to the dA-plus-dT content of C. perfringens chromo- somal DNA (28) . The pfoA gene extended from position 2962 to position 4461 (Fig. 2) . Our sequence contained an additional 3 bp in the pfo coding sequence of C. perfringens ATCC 13124 compared with the sequence reported by Tweten (32). These differences (at coordinates 3337, 3341, and 3344) resulted in mismatches in the deduced amino acid sequence at positions 126 and 127.
Upstream from the pfoA gene there was a main open reading frame (ORF) (from position 1343 to position 2371), which coded for 343 amino acids. This ORF was preceded by a putative ribosome-binding site (8 bp upstream) and was followed by a putative rho-independent transcriptional terminator (24) . It contained eight Ser-Pro-X-X, Thr-Pro-X-X, and related motifs, which appear frequently in gene-regulatory proteins (29) (Fig. 2) . In addition, another important motif of gene-regulatory proteins, a helix-turn-helix (23) , was present (Fig. 2) . The ORF did not code for a signal peptide sequence (34) , indicating that it coded for a nonsecretory protein. These results suggest that the ORF might encode a regulatory protein for the pfoA gene. Therefore, it was tentatively designated the pfoR gene.
In addition to pfoR, there were two other ORFs. One started at position 673, and the other started at position 2061 in the direction opposite to that of the pfoA gene. The former (ORF1) possessed a putative ribosome-binding site, but the latter (ORF2) lacked such a site. ORFi was not interrupted by a stop codon in the insertion of pTS301. ORF2 was located inside pfoR. The two flanking regions (Fl, located between ORFi and pfoR, and F2, located between pfoR and pfoA) had many palindromic structures. F2 also contained three different direct repeats (Fig. 2) .
Effects of the pfoR gene on pfoA gene expression. A series of deletion plasmids were constructed (Fig. 3) and assayed for hemolytic activity (Table 1 ). pTS301 and pTS302, which contained the intact pfoR gene, had approximately 20 times higher activity than the other plasmids, from which the pfoR gene was deleted. Northern blot hybridization showed that pfoA mRNA was approximately 1.8 kb long (data not shown), indicating that transcription from a pfoA promoter does not affect transcription of bla mRNA. Therefore, f-lactamase activity should have been proportional to plasmid copy number (6) and was used to correct hemolytic activity. For cells carrying pTS301 and pTS302, P-lactamase activities were much lower and growth was much slower than the activities and growth of other cells. Therefore, overproduction of perfringolysin 0 seemed to be toxic to the cells, causing a decrease in plasmid copy number. Deletion of a small fragment inside the pfoR gene (87-bp HindlIlHindIII fragment) decreased the hemolytic activity to the same level as pTS313, which contained only the pfoA gene, as expected. The deletion of the 87-bp fragment removed the helix-turn-helix motif without a frame shift mutation in the coding frame of the pfoR gene, indicating not only that the pfoR gene was primarily involved in activation of the pfoA gene but also that the helix-turn-helix motif played an essential role in this activation.
To determine whether the pfoR gene has a trans-acting effect on pfoA gene expression, two plasmids were constructed so that the two genes could be located on different replicons (the pfoR gene on pUC19 and the pfoA gene on pACYC177). The hemolytic activity of E. coli JM109 carrying the two plasmids was compared with the hemolytic activity of a control carrying pUC19 and pACYC177-pfoA. There was no significant difference between the two cultures. Therefore, we looked for a trans-acting effect by using plasmids in which the pfoR and pfoA genes were located on the same plasmid but their relative positions differed from the original positions. For this purpose, pTS410 and pTS411, which had the pfoR gene downstream from the pfoA gene, were constructed from pTS302 (Fig. 3) . Both plasmids had significantly higher hemolytic activity than pTS313, which contained only the pfoA gene. The hemolytic activity of pTS411 was about twofold higher than that of pTS410 but four-to five-fold lower than that of pTS302, reflecting differences in the arrangement of the two genes (see below). These results indicate that the pfoR gene can be trans acting, although it is more efficient in cis than in trans. This supports our hypothesis that it encodes a regulatory protein of the pfoA gene.
DISCUSSION
The data presented above clearly indicate that the main ORF (designated pfoR) that is present upstream from the pfoA gene functions to enhance pfoA gene expression in E.
coli. The results of a search for putative promoters by computer analysis suggested the presence of some functional promoters, although such promoters have not been clearly identified. All of the putative promoters seem to be weak in E. coli, and hence the product of pfoR would be present in low amounts. The pfoR gene failed to activate the expression of a pfoA gene on a different plasmid. Furthermore, changes in the relative positions and orientations of the two genes subtly affected expression. Therefore, a local concentration of nascent pfoR gene product seems to be critically important for effective control. Many procaryotic regulatory polypeptides and RNAs which can act more efficiently in cis have been described (1) . This cis-dominant control allows effective control by low concentrations of the regulatory molecule.
In addition, the deduced amino acid sequence of pfoR contains a helix-turn-helix motif and many Ser-Pro-X-X, Thr-Pro-X-X, and related motifs which are frequently found in DNA-binding proteins (23, 29) . These characteristics suggest that pfoR may regulate the pfoA gene by binding to some site near the pfoA gene. Region F2, which is located between the pfoR and pfoA genes, contains direct repeats in the region immediately preceding the pfoA gene. In general, direct repeats have been shown to be binding sites for positive regulators in many regulatory systems (5, 8, 15, 20) . The direct repeats found in region F2 are a potential pfoR binding site.
Imagawa et al. (10) stated that the production of four clostridial virulence factors, perfringolysin 0, collagenase, hemagglutinin, and protease, are under the same genetic control. If this is the case, pfoR should play a key role in the expression of not only the pfoA gene but also of genes encoding the other three toxins. Considering the cis-dominant control of this system, these four toxin genes should be topologically linked on the chromosome. Canard and Cole established a physical map of the genome of C. perfringens comprising some 24 genes and found that three of the four virulence factor genes are located in a 200-kb region of the chromosome (3). These authors suggested the possibility that genes encoding virulence factors might be clustered near the putative replication origin.
Many genes of thiol-activated hemolysins have been cloned and sequenced (11, 18, 33) . Since all of these genes are very similar, it can be expected that some of them, if not all, are controlled in a similar manner. However, there is no distinctive homology between the pfoR gene and the listeriolysin 0 regulator gene described by Mengaud et al. (19) . The regulation of other thiol-activated hemolysin genes must be elucidated to draw a conclusion concerning this hypothesis.
All of the experiments in this study were carried out by using E. coli. It is possible that the expression of the pfoA gene is regulated in a different manner in C. perfringens than in E. coli. Garnier and Cole found that RNA polymerase from vegetative C. perfringens cells showed the same promoter specificity as other eubacterial polymerases (7). Therefore, it seems likely that both the pfoR and pfoA genes VOL. 59, 1991 on September 30, 2017 by guest http://iai.asm.org/ Downloaded from are expressed in C. perfringens as they are in E. coli. However, the possibility described above cannot be eliminated. Further detailed study of the pfoR gene product in C. perfringens and its effect on pfoA gene expression will be necessary to draw a conclusion concerning positive regulation.
